Clinical Trial Details
— Status: Withdrawn
Administrative data
NCT number |
NCT04730076 |
Other study ID # |
44391 |
Secondary ID |
|
Status |
Withdrawn |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 13, 2020 |
Est. completion date |
September 1, 2022 |
Study information
Verified date |
November 2022 |
Source |
University of Kentucky |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This is the first head to head, prospective, randomized, double-blind clinical trial
comparing two different approaches of balloon dilation (standard versus progressive dilation)
for benign esophageal strictures. A retrospective study on patients with benign esophageal
strictures that underwent balloon dilation using the proposed technique found considerable
symptomatic improvement in dysphagia. The proposed balloon dilation method is a novel
approach that will require fewer sessions of dilation and use fewer balloon dilation
catheters to achieve a maximum balloon diameter of 18mm and result in a significant
symptomatic improvement.
Description:
Benign esophageal strictures are a frequently encountered problem in the clinical practice of
gastroenterology. The formation of benign strictures of the esophagus is believed to be
caused by the production of fibrous tissue and deposition of collagen stimulated by deep
esophageal ulceration or chronic inflammation. The most common cause of esophageal stricture
is a peptic stricture, which is caused by reflux esophagitis. Gastroesophageal reflux disease
(GERD) affects approximately 40% of adults and if left untreated 7-25% will develop a peptic
stricture. Other common causes include radiation, caustic ingestions, anastomotic strictures,
and eosinophilic esophagitis-associated strictures. Patients with an esophageal stricture
characteristically have dysphagia (difficulty swallowing) to solid food instead of liquids.
Other symptoms could include regurgitation of food and liquids, sensation that food is stuck
in the chest after eating, and heartburn. Dysphagia can have a severe and deleterious impact
on quality of life of these patients and lead to complications such as aspiration, weight
loss and malnutrition.
According to the literature, esophageal strictures are structurally categorized into two
groups: simple and complex. Simple strictures are concentric with a diameter of >12 mm or
easily allow passage of a diagnostic upper endoscope. Complex strictures are usually long,
asymmetric, diameter <12 mm or inability to pass an endoscope. Complex strictures are more
difficult to treat and tend to be refractory despite adequate dilation therapy.
The standard management approach of benign strictures is dilation therapy. The mechanistic
action of the balloon dilators is they distribute the dilating force radially and
simultaneously across the entire length of the stricture. Balloon dilators can be passed
through-the-scope (TTS) or over a guide-wire. Once the balloon dilator catheter is passed
through the endoscope, it is positioned so that the narrowest portion of the stricture is at
the center of the balloon. The dilators are typically inflated with water (or radio-opaque
material if performed under fluoroscopy) to pressures that correspond to specific dilation
diameters. The degree of dilation within a session should be based on the severity of the
stricture by estimating the stricture diameter, followed by serial increases in the diameter
of the dilating balloon. There are no data on the optimal duration the balloon should remain
inflated, but national and international guidelines recommend inflation times from 30 to 60
seconds.
Balloon dilation has been the primary method for treating benign esophageal strictures for
decades due to its effectiveness and safety. According to the current medical literature,
about 80-90% of patients have relief of dysphagia but unfortunately, about 30-40%of patients
eventually have a recurrence of dysphagia and require repeat dilation. Predictors for
recurrence include the presence of a complex stricture, persistence of heartburn symptoms,
presence of non-acid related strictures (radiation-induced or caustic ingestion), and
eosinophilic esophagitis. Generally, the last dilator used in the previous dilation session
should be used first.
There is also no consensus regarding how frequent the interval of balloon dilations should be
performed. Helsema et al, conducted a retrospective study to determine the optimal target of
endoscopic dilation of postsurgical esophageal strictures. Eighty-eight patients were dilated
up to a maximum diameter of 16 mm and 91 patients to a diameter >16 mm. The stricture
recurrence rate was 79.5 % in the 16 mm group and 68.1 %in the >16 mm group. They concluded
that endoscopic dilation over 16 mm resulted in a significant prolongation of the
dilation-free period in comparison with dilation up to 16 mm in patients with benign
anastomotic strictures after esophagectomy. Pereira-Lima et al performed 1043 dilation
sessions on 153 patients. Stricture's etiology was postsurgical in 80 patients, peptic in 37,
caustic in 12, and from other causes in 11 patients. Adequate dilation was achieved in 93.5%
of the patients (131 of 140). Patients with peptic strictures needed a median of three
sessions to be adequately dilated during follow-up in comparison to five sessions among
patients with postsurgical or caustic strictures. They concluded that endoscopic dilation is
safe and effective in relieving dysphagia caused by benign strictures of different causes,
although frequently repeated sessions are necessary because of stricture recurrence.